Rocket Lab Just Won $663 Million in Space Force Contracts. Only the Bigger One Waits for a Rocket That Has Never Flown.

Rocket Lab won $397M from the U.S. Space Force to build, launch, and operate SB-AMTI satellites, alongside a separate $266M Space Force suborbital launch contract for 12 guaranteed missions (options up to 18), totaling $663M in new work in about a week. The $266M portion largely relies on already-flying hardware, with the first Kodiak, Alaska launch expected as soon as end-2026, while the $397M award is gated behind Neutron’s debut launch (targeted late this year but previously slipped). Shares rose ~6% on the day; however, at ~65x trailing revenue and with no net income, investors will likely focus on any Neutron schedule updates in upcoming results.

Analysis

The near-term winner is RKLB, but the more important read-through is that the company is being valued less like a launch pure-play and more like an integrated defense-space platform. That matters because it can support multiple expansion only if management proves it can convert government awards into recurring, scheduleable revenue with acceptable gross margin; otherwise the market will keep discounting these wins as long-dated backlog rather than earnings power. The suborbital piece is the cleaner monetization path and should help near-term confidence in cash conversion, while the Neutron-linked award is effectively an option on execution.

The key risk window is the next 1-3 months, centered on earnings and any Neutron schedule update. A slip in first flight would likely hit the stock harder than the headline contract size helps it, because the market is already capitalizing future launch cadence and not just signed backlog. Over 6-18 months, the bigger issue is whether RKLB can scale from a good launch operator into a repeatable prime contractor; if not, the company will keep raising expectations faster than revenue recognition catches up.

Consensus may be too focused on the contract value and not enough on timing and margin quality. The market is likely underestimating the possibility that the supposedly "bigger" award contributes less near-term P&L than the smaller award because it is gated by an unproven vehicle and likely heavier upfront investment. If Neutron flies on schedule, the multiple can rerate sharply; if not, this becomes a classic backlog-versus-earnings disappointment.

Key Decisions for Investors

• Long RKLB into a successful Neutron debut only; otherwise avoid chasing the post-announcement pop. Best entry is on any pullback after earnings if management reaffirms late-2026/early-2027 launch cadence.
• Use a defined-risk structure: RKLB Nov/Jan call spread to express upside to a first-flight confirmation while limiting downside if the schedule slips.
• Pair trade idea: long RKLB / short XAR as a relative-value bet that execution-specific alpha in small-cap space beats broad aerospace-defense beta over the next 1-3 months.
• Set a hard falsifier: if Neutron timing moves meaningfully beyond year-end or capex/cash-burn guidance steps up without corresponding launch certainty, reduce exposure.